Impairment of exercise capacity and peak oxygen consumption in patients with mild left ventricular dysfunction and coronary artery disease

European Heart Journal

Volumn 19, Issue 11, 1998, Pages 1688-1695

  Nieuwland, W ^a,b   Berkhuysen, M A ^b   Van Veldhuisen, D J ^a   Van Sonderen, E ^c   Viersma, J W ^a   Lie, K I ^a   Rispens, P ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c N Center for Healthcare Research   (Netherlands)

Author keywords

Anaerobic threshold; Coronary disease; Exercise capacity; Heart failure; Peak V(O2)

Indexed keywords

OXYGEN;

ADULT; AGED; ANAEROBIC THRESHOLD; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXERCISE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANAEROBIC THRESHOLD; CORONARY DISEASE; EXERCISE TEST; EXERCISE TOLERANCE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032212470     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1149     Document Type: Article

References (43)

1. [1] Cohn JN, Johnson GR, Shabetai R et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993; 87 (Suppl VI): VI5-VI16.
2. [2] Van den Broek SAJ, Van Veldhuisen DJ, De Graeff PA, Landsman MLJ, Hillige H, Lie KI. Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 70: 359-63.
3. [3] Franciosa JA, Park M, Levine BT. Lack of correlation between exercise capacity and indices of resting left ventricular performance in heart failure. Am J Cardiol 1981; 47: 33-9.
4. [4] LeJemtel TH, Linag C, Stewart DK et al. Reduced peak aerobic capacity in asymptomatic left ventricular dysfunction. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 1994; 90: 2757-60.
5. [5] Packer M. Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure. Circulation 1990; 81 (Suppl III): III-78-III-86.
6. [6] Cohn JN, Johnson G and Veterans Administration Cooperative Study Group. Heart failure with normal ejection fraction. The V-HeFT Study. Circulation 1990; 81 (Suppl III): III-48-III-53.
7. [7] Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation 1982; 65: 1213-33.
8. [8] Cohen-Solal A, Gourgon R. Assessment of exercise tolerance in chronic congestive heart failure. Am J Cardiol 1991; 67: 36c-40c.
9. [9] Francis GS, Rector TS. Maximal exercise tolerance as a therapeutic end point in heart failure - are we relying on the right measure? Am J Cardiol 1994; 73: 304-36.
10. [10] Astrand PO, Rodahl K. Textbook of Work Physiology, 3rd edn. New York: McGraw-Hill Company, 1986: 354-90.
11. [11] Itoh H, Taniguchi K, Koike A, Doi M. Evaluation of severity of heart failure using ventilatory gas analysis. Circulation 1990; 81 (Suppl I): II-31-II-37.
12. [12] Higginbotham MB, Morris KG, Williams RS, Coleman E, Cobb F. Physiologic basis for the age-related decline in aerobic work capacity. Am J Cardiol 1986; 1374-9.
13. [13] DiSalvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995; 25: 1143-53.
14. [14] Stelken AM, Younis LT, Jennison SH et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 1996; 27: 345-52.
15. [15] Jones NL, Campbell EJM. Clinical exercise testing, 2nd edn. Philadelphia: WB Saunders Co, 1982: 249.
16. [16] Wasserman K, Beaver WL, Whipp BJ. Gas exchange theory and the lactic acidosis (anaerobic) threshold. Circulation 1990; 81; II-14-II-30.
17. [17] Henry WL, DeMaria A, Gramiak R et al. Report of the American Society of Echocardiography. Nomenclature and standards in two-dimensional echocardiography. Circulation 1980; 62: 212.
18. [18] Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, subcommittee on Quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67.
19. [19] Wasserman K, Hansen JE, Sue DY, Whipp BJ. Principles of exercise testing and interpretation. Philadelphia: Lea and Febiger, 1987: 75.
20. [20] The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-91.
21. [21] Van Veldhuisen DJ, Brouwer J, Man in't Veld AJ, Dunselman PHJM, Boomsma F, Lie KI. Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. Am J Cardiol 1995; 75: 796-800.
22. [22] Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A, for the V-HeFT VA Cooperative Studies Group. Plasmanorepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. Circulation 1993; 87: VI-40-VI-48.
23. [23] The SOLVD Investigators. Effect of enalapril on survival in patients reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293-302.
24. [24] CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe heart failure: results of the Co-operative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-35.
25. [25] Packer M, Carver JR, Rodeheffer RJ et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991; 325: 1468-75.
26. [26] Feldman AM, Bristow MR, Parmley WM et al. Effects of vesnarinone on morbidity and mortality in patients with heart failure. N Engl J Med 1993; 329: 149-55.
27. [27] Carson P, Johnson G, Fletcher R, Cohn JN. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the vasodilator in heart failure trials (V-HeFT). J Am Coll Cardiol 1996; 26: 642-9.
28. [28] The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992; 327: 685-91.
29. [29] Stratton JR, Dunn JF, Adamopoulos S, Kemp GJ, Coats AJS, Rajagopalan B. Training partially reverses skeletal muscle metabolic abnormalities during exercise in heart failure. J Appl Physiol 1994; 76: 1575-182.
30. [30] Wilson JR, Rayos G, Yeoh TK, Gothard P, Bak K. Dissociation between exertional symptoms and circulatory function in patients with heart failure. Circulation 1995; 92: 47-53.
31. [31] Wilson JR, Mancini DM. Skeletal muscle metabolic dysfunction. Implications for exercise intolerance in heart failure. Circulation 1993; 87 (Suppl VII): VII-104-VII-109.
32. [32] Coats AJS, Adamopoulos S, Radaelli A et al. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation and autonomic function. Circulation 1992; 85: 2119-31.
33. [33] Davis JA, Frank MH, Whipp BJ, Wasserman K. Anaerobic threshold alterations caused by endurance training in middle-aged men. J Appl Physiol 1979; 46: 1039-46.
34. [34] Blumenthal JA, Emery CF, Madden DJ, Coleman RE, Riddle MW, Schniebolk S, Cobb FR, Sullivan MJ, Higginbotham MB. Effects of exercise training on cardiorespiratory function in men and women >60 years of age. Am J Cardiol 1991; 67: 633-9.
35. [35] Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction: hemodynamic and metabolic effects. Circulation 1988; 78: 506-15.
36. [36] Wasserman K. Reduced aerobic enzyme activity in skeletal muscles of patients with heart failure. A primary defect or a result of limited cardiac output. Circulation 1991; 84: 1868-70.
37. [37] Belardinelli R, Georgiou D, Cianci G, Berman N, Gintzon L, Purcaro A. Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy. Clinical and prognostic implications. Circulation 1995; 91: 2775-84.
38. [38] Pollock ML, Wilmore JH. Exercise in health and disease, 2nd edn. Philadelphia: WB Saunders Company, 1990: 128-38.
39. [39] Landin RJ, Linnemeier TJ, Rothbaum DA, Chappelear J, Noble RJ. Exercise testing and training of the elderly patient. In: Exercise and the Heart. Philadelphia: FA Davis Company, 1985: 201-18.
40. [40] Martin WH, Ogawa T, Kohrt WM et al. Effects of aging, gender, and physical training on peripheral vascular function. Circulation 1991; 84: 654-64.
41. [41] Cohen-Solal A, Aupetit JF, Gueret P, Kolsky H, Zannad F. Can anaerobic thresholds be used as an end-point for therapeutic trials in heart failure? Lessons from a multicentre randomized placebo-controlled trial. Eur Heart J 1994; 15: 236-41.
42. [42] Dickstein K, Barvik S, Aarsland T, Snapinn S, Karlsson J. A comparison of methodologies in detection of the anaerobic threshold. Circulation 1990; 81: II-38-II-46.
43. [43] Meyer K, Westbrook S, Schwaibold M, Hajric R, Peters K, Roskamm H. Short-term reproducibility of cardio-pulmonary measurements during exercise testing in patients with severe heart failure. Am Heart J 1997; 134: 20-6.